Philip Morris International Inc.
PM NYSEConsumer Defensive ★★★★★| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 22, 2026 | -- | 2.05 | 2.20 | $10.6B | $11.19B |
| Apr 22, 2026 | -- | 1.86 | 1.96 | $9.95B | $10.15B |
| Feb 6, 2026 | -- | 1.70 | 1.70 | $10.4B | $10.36B |
| Oct 21, 2025 | -- | 2.09 | 2.24 | $10.64B | $10.85B |
| Jul 22, 2025 | -- | 1.86 | 1.91 | $10.32B | $10.14B |
| Apr 23, 2025 | -- | 1.61 | 1.69 | $9.14B | $9.3B |
| Feb 6, 2025 | -- | 1.49 | 1.55 | $9.44B | $9.71B |
| Oct 22, 2024 | -- | 1.82 | 1.91 | $9.68B | $9.91B |
| Jul 23, 2024 | -- | 1.57 | 1.59 | $9.19B | $9.41B |
| Apr 23, 2024 | -- | 1.41 | 1.50 | $8.44B | $8.79B |
| Feb 8, 2024 | -- | 1.45 | 1.36 | $9.01B | $9.05B |
| Oct 19, 2023 | -- | 1.61 | 1.67 | $8.94B | $9.14B |
| Jul 20, 2023 | -- | 1.48 | 1.60 | $8.65B | $8.97B |
| Apr 20, 2023 | -- | 1.34 | 1.38 | $8.11B | $8.02B |
| Feb 9, 2023 | -- | 1.24 | 1.39 | $7.5B | $8.15B |
Philip Morris International Inc. (PM) is a global tobacco company primarily engaged in the manufacture and sale of cigarettes, and increasingly, smoke-free products. Its portfolio includes some of the world's best-known international and local cigarette brands, sold across various markets outside the United States. In recent years, the company has significantly pivoted its strategy towards developing and commercializing reduced-risk products (RRPs), particularly heated tobacco products, aiming to build a future without cigarettes. This strategic shift involves substantial investment in research and development, manufacturing capabilities, and marketing for these new product categories.
As a leader in the global tobacco industry, Philip Morris International holds significant market share in numerous countries, benefiting from established distribution networks and strong brand recognition. The competitive landscape is characterized by a few large multinational players and various local companies. Competition extends beyond traditional cigarettes to the rapidly evolving smoke-free product segment, where innovation, regulatory navigation, and consumer adoption are key differentiators. The company's scale and extensive market reach provide a competitive advantage, particularly in emerging markets where tobacco consumption patterns may differ from developed regions.
When Philip Morris International reports its earnings, investors typically focus on several key metrics. Revenue growth, particularly from smoke-free products, is closely watched as an indicator of the company's transformation progress. Shipment volumes for both traditional cigarettes and RRPs provide insights into market demand and brand performance. Profitability metrics such as operating income and earnings per share (EPS) are crucial for assessing overall financial health. Additionally, cash flow generation is important, given the company's history of significant dividend payouts and share repurchase programs. Investors also pay close attention to the performance of key RRP brands, their market penetration, and the regulatory environment surrounding these products in various geographies.
The company's performance is subject to several cyclical and risk factors. Tobacco consumption trends can be influenced by public health campaigns, changing consumer preferences, and economic conditions. Regulatory risks are substantial, encompassing excise taxes, marketing restrictions, plain packaging mandates, and evolving regulations specifically for smoke-free products, which can vary significantly by country. Currency fluctuations also pose a risk, given the company's extensive international operations. The transition to smoke-free products, while a strategic imperative, involves execution risks related to product development, consumer acceptance, and the ability to scale production and distribution effectively. Litigation risks, common in the tobacco industry, also remain a consideration.
